This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Wells P, Diamantopoulos A, McDonald H, Forster F, Lereun C, Rasul F, Lees M.Economic comparison of rivaroxaban with dabigatran in Canadian patients undergoing total hip replacement. 22nd Congress of the International Society on Thrombosis and Haemostasis: 201 abstr. OC-WE-005, 11 Jul 2009. Available from: URL: http://www.isth2009.com
Rights and permissions
About this article
Cite this article
Rivaroxaban cost-effective over dabigatran after THR. Pharmacoecon. Outcomes News 583, 9 (2009). https://doi.org/10.2165/00151234-200905830-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905830-00019